![Mark Hollywood](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Hollywood
Chief Operating Officer at
ZYMEWORKS INC.
Net worth: 3 M $ as of 30/06/2026
Profile
Mark Hollywood is currently EVP & Head-Technical & Manufacturing Operations at Zymeworks BC, Inc. since 2019.
Mr. Hollywood is also Chief Operating Officer & Executive Vice President at Zymeworks, Inc., with the COO & EVP title starting in 2026.
Formerly, Mr. Hollywood was Vice President & Head-ZymoGenetics at Bristol Myers Squibb Co. from 2010 to 2019.
Mr. Hollywood was Director-Quality Assurance & Quality Control at CellCyte Genetics Corp.
Mr. Hollywood completed undergraduate education at Western Illinois University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ZYMEWORKS INC. 0.18% | 06/07/2026 | 1,33,852 ( 0.18% ) | 3 M $ | 30/06/2026 |
Mark Hollywood active positions
| Companies | Position | Start |
|---|---|---|
| ZYMEWORKS INC. | Chief Operating Officer | 09/01/2026 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Chief Tech/Sci/R&D Officer | 30/04/2019 |
Former positions of Mark Hollywood
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2019 |
| CELLCYTE GENETICS CORPORATION | Corporate Officer/Principal | - |
Training of Mark Hollywood
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
CellCyte Genetics Corp.
 CellCyte Genetics Corp. Miscellaneous Commercial ServicesCommercial Services Develops stem cell therapeutic products | Commercial Services |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Western Illinois University
 Western Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Mark Hollywood
